Clinically-important venous thromboembolism following lower extremity fractures: epidemiology & prevention
Phase of Trial: Phase IV
Latest Information Update: 06 Jul 2007
At a glance
- Drugs Dalteparin sodium (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- Acronyms D-KAF
- 06 Jul 2007 Results have been reported.
- 11 Dec 2005 New trial record.